Kazia Therapeutics (KZIA) Gross Margin (2009)
Kazia Therapeutics (KZIA) reported Gross Margin of 107.31% for the year ended Jun 30, 2011, up 7.31 percentage points from 100.00% a year earlier.
Powered by 
Analysis
Kazia Therapeutics (KZIA) Gross Margin (2009) Analysis & Trends
- According to Business Quant data, Gross Margin came in at 100.00% in the year ended Jun 30, 2010 (+22.63 pp) and 77.37% in the year ended Jun 30, 2009.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 85.78% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 68.19% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 74.74% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 73.54% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 78.02% |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 83.60% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 72.04% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 79.76% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 72.78% |
| 10 | Kazia Therapeutics | 606,664.05 | -51.76 Mn | - | - |
API Access
Kazia Therapeutics Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=KZIA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "KZIA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=KZIA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();